Features of supply and approaches to the use of vitamin D in children in the post-COVID period

   Vitamin D is an important component of immune function, and deficiency in childhood is associated with an increased risk of acute respiratory viral infections.
   Purpose. To assess the dynamics of vitamin D supply in children after a new coronavirus infection with the use of cholecalciferol.

   Material and methods. We examined 55 children aged 0–17 years (10.0 [9.2; 10.6] years), 52.7 % boys with COVID-19, who received cholecalciferol in a dose of 1000 to 3000 IU for 30 days in depending on the concentration of 25(OH)D. After 30 days of taking vitamin D3, the levels of total vitamin D in the blood serum were re-determined.

   Results. The median 25(OH)D level in children with COVID-19 was 24.5 [23.9; 26.7] ng/ml. 34.5 % of children had vitamin D deficiency status (≤ 20 ng/ml), 32.7 % had insufficiency (21–30 ng/ml), a third of patients had normal vitamin D status (≥ 30 ng/ml). As a result of treatment with cholecalciferol, the number of children with hypovitaminosis D decreased by 2 times (35.4 %, p < 0.05), with an adequate level — doubled (65.5 %, p < 0.05). Depending on the level of 25(OH)D, no statistically significant differences were found in the severity of coronavirus infection (χ² = 0.872, p = 0.929).

   Conclusion. In 2/3 of cases, children infected with SARS-CoV-2 had hypovitaminosis D. Children under 6 years of age were more likely to have vitamin D insufficiency, while patients 7–17 years of age had a deficiency. The distribution of vitamin D levels did not differ depending on the severity of coronavirus infection. Doses of cholecalciferol taken for 30 days were sufficient to increase the concentration of vitamin D in the blood serum of children with deficiency but did not reach standard values in patients with vitamin D deficiency.

1. Zakharova I.N., Klimov L.Yа., Kuryaninova V.A., Dolbnya S.V., Maikova I.D., Kasyanova A.N. et al. Vitamin D provision for babies. Ros Vestn Perinatol i Pediatr 2016; 61: (6): 68–76. (in Russ.) DOI: 10.21508/1027–4065–2016–61–6–68–76

2. Polenova N.V., Varaeva Yu.R., Livantsova E.N., Vikent’ev D.V., Kosyura S.D., Starodubova A.V. Vitamin D in the Elderly and Senile Patients: Focus on COVID-19. Lechebnoe delo 2021; 3: 65–74. (in Russ.) DOI: 10.24412/2071–5315–2021–12361

3. Alpcan A., Tursun S., Kandur Y. Vitamin D levels in children with COVID-19: a report from Turkey. Epidemiol Infect 2021; 149: e180. DOI: 10.1017/S0950268821001825

4. Marik P.E., Kory P., Varon J. Does vitamin D status impact mortality from SARS-CoV-2 infection? Med Drug Discov 2020; 6: 100041. DOI: 10.1016/j.medidd.2020.100041

5. Karimian P., Tahami M.S., Sayyahfar S., Aghajani Delavar M. Association of vitamin D and severity of COVID-19 in children. Eur J Translat Myol 2022; 32(2): 10453. DOI: 10.4081/ejtm.2022.10453

6. Rondanelli M., Miccono A., Lamburghini S., Avanzato I., Riva A., Allegrini P. et al. Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common Colds. Evidence-based complementary and alternative medicine: eCAM 2018; 2018: 5813095. DOI: 10.1155/2018/5813095

7. Grant W.B., Lahore H., McDonnell S.L., Baggerly C.A., French C.B., Aliano J.L. et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients 2020; 12(4): 988. DOI: 10.3390/nu12040988

8. Ceramella J., Iacopetta D., Sinicropi M.S., Andreu I., Mariconda A., Saturnino C. et al. Drugs for COVID-19: An Update. Molecules 2022; 27: 8562. DOI: 10.3390/molecules27238562

9. Iacopetta D., Ceramella J., Catalano A., Saturnino C., Pellegrino M., Mariconda A. et al. COVID-19 at a Glance: An Upto-Date Overview on Variants, Drug Design and Therapies. Viruses 2022; 14: 573. DOI: 10.3390/v14030573

10. Barrea L., Verde L., Grant W.B., Frias-Toral E., Sarno G., Vetrani C. et al. Vitamin D: A Role Also in Long COVID-19? Nutrients 2022; 14: 1625. DOI: 10.3390/nu14081625

11. Hansdottir S., Monick M.M. Vitamin D effects on lung immunity and respiratory diseases. Vitamin Hormon 2011; 86: 217–237. DOI: 10.1016/B978–0–12–386960–9.00009–5

12. Mingazova E.N., Gureev S.A., Sidorov V.V. The role of supplying population with vitamin D in conditions of COVID-19 pandemic: foreign publications review. Problemi sotsial’noi gigieni, zdravookhraneniya i istorii meditsini 2021; 29(1): 32–36. (in Russ.) DOI: 10.32687/0869–866X-2021–29–1–32–36

13. Nadiger M., Hassor S., Totapally B. 138: vitamin D levels in children with COVID-19 admitted to the PICU. Critical Care Med 2021; 49(1): 54.

14. Maksimov M.L., Zvegintseva A.A., Ismailova M.A., Kulagina L.Yu. Vitamin D in prophylactics of contamination and development of severe forms of the new coronavirus infection COVID-19. Prakticheskaya meditsina 2021; 19(4): 37–44. (in Russ.) DOI: 10.32000/2072–1757–2021–4–37–44

15. Zhou J., Du J., Huang L., Wang Y., Shi Y., Lin H. Preventive Effects of Vitamin D on Seasonal Influenza A in Infants: A Multicenter, Randomized, Open, Controlled Clinical Trial. Pediatr Infect Dis J 2018; 37(8): 749–754. DOI: 10.1097/INF.0000000000001890

16. Aglipay M., Birken C.S., Parkin P.C., Loeb M.B., Thorpe K., Chen Y. et al.; TARGet Kids! Collaboration. Effect of High-Dose vs Standard-Dose Wintertime Vitamin D Supplementation on Viral Upper Respiratory Tract Infections in Young Healthy Children. JAMA 2017; 318(3): 245–254. DOI: 10.1001/jama.2017.8708

17. National program «Vitamin D deficiency in children and adolescents of the Russian Federation: modern approaches to correction». Union of Pediatricians of Russia. Moscow: Pediatr, 2021; 116. (in Russ.)

18. Pinzon R.T., Angela, Pradana A.W. Vitamin D deficiency among patients with COVID-19 : case series and recent literature review. Tropical Med Health 2020; 48(1): 102. DOI: 10.1186/s41182–020–00277-w

19. Sánchez-Zuno G.A., González-Estevez G., Matuz-Flores M.G., Macedo-Ojeda G., Hernández-Bello J., Mora-Mora J.C. et al. Vitamin D Levels in COVID-19 Outpatients from Western Mexico: Clinical Correlation and Effect of Its Supplementation. J Clin Med 2021; 10(11): 2378. DOI: 10.3390/jcm10112378

20. Alipio M. Vitamin D supplementation could possibly improve clinical outcomes of patients infected with coronavirus-2019 (COVID-19). SSRN Electronic Journal. Available at SSRN 3571484. 2020. DOI: 10.2139/ssrn.3571484

21. Yılmaz K., Şen V. Is vitamin D deficiency a risk factor for COVID-19 in children? Pediatr Pulmonol 2020; 55(12): 3595–3601. DOI: 10.1002/ppul.25106

22. Karonova T.L., Andreeva A.T., Vashukova M.A. Serum 25(OH)D level in patients with CoVID-19. Zhurnal infektologii 2020; 12(3): 21–27. (in Russ.) DOI: 10.22625/2072–6732–2020–12–3–21–27

23. Shrayner E.V., Petukhova S.K., Khavkin A.I., Kokh N.V., Lifshits G.I. Association of genetic prerequisites of vitamin d defi ciency with severity of past COVID-19 infection. Eksperimental’naya i klinicheskaya gastroenterologiya 2022; 202(6): 50–55. (in Russ.) DOI: 10.31146/1682–8658-ecg-202–6–50–55

24. Petrikov S.S., Savkov G.E., Godkov M.A., Borovkova N.V., Kvasnikov A.M., Lebedev D.A., et al Effect of vitamin D (25-OH D3) concentration on the course and outcomes of COVID-19 in intensive care patients. Anesteziologiya i reanimatologiya 2022; 5: 30–35. (in Russ.) DOI: 10.17116/anaesthesiology202205130